Medical records were searched for dogs that had received curative intent surgery for oral malignant melanoma and ipsilateral excisional regional lymph node biopsy. Twenty-seven dogs were operated on and 25 dogs of these dogs met the inclusion criteria of signalment, post-excision margin status, presence of metastasis for each biopsied lymphocentrum, survival time post-excision, presence of recurrence or metastasis at follow-up or at death/euthanasia, location of the primary tumor, and any postoperative adjuvant treatment. These 25 dogs had complete tumor excision with tumor-free margins and 19 (76%) had postoperative adjuvant therapy. Median survival time after excision for the dogs in this study was 335.5 days. Results of this study support previous work that documents prolonged survival time following complete excision of oral malignant melanoma with tumor-free surgical margins in dogs. Additionally, 4 dogs (16%) had histologically confirmed regional lymph node metastasis at the time of definitive surgery.
BergJ. Principles of oncologic orofacial surgery. Clin Tech Small Anim Pract.1998;13(1):38-41.
2.
BergmanPJ. Canine oral melanoma. Clin Tech Small Anim Pract.2007;22(2):55-60.
3.
TuohyJLSelmicLEWorleyDREhrhartNPWithrowSJ. Outcome following curative-intent surgery for oral melanoma in dogs: 70 cases (1998–2011). J Am Vet Med Assoc. 2014;245(11):1266-1273.
4.
HarveyHJMacEwenEGBraunDPatnaikAKWithrowSJJongewardS. Prognostic criteria for dogs with oral melanoma. J Am Vet Med Assoc.1981;178(6):580-582.
5.
EsplinDG. Survival of dogs following surgical excision of histologically well-differentiated melanocytic neoplasms of the mucous membranes of the lips and oral cavity. Vet Pathol.2008;45(6):889-896.
6.
Ramos-VaraJABeissenherzMEMillerMA, et al. Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases. Vet Pathol.2000;37(6):597-608.
7.
ProulxDRRuslanderDMDodgeRK, et al. A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation. Vet Radiol Ultrasound.2003;44(3):352-359.
8.
TreggiariEGrantJPNorthSM. A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma. J Vet Med Sci.2016;78(5):845-850.
9.
KawabeMMoriTItoY, et al. Outcomes of dogs undergoing radiotherapy for treatment of oral malignant melanoma: 111 cases (2006–2012). J Am Vet Med Assoc.2015;247(10):1146-1153.
10.
BostonSELuXCulpWT, et al. Efficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases (2001–2012). J Am Vet Med Assoc.2014;245(4):401-407.
11.
OttnodJMSmedleyRCWalshawRHauptmanJGKiupelMObradovichJE. A retrospective analysis of the efficacy of oncept vaccine for the adjunct treatment of canine oral malignant melanoma. Vet Comp Oncol.2013;11(3):219-229.
12.
WestbergSSadeghiASvenssonE, et al. Treatment efficacy and immune stimulation by AdCD40L gene therapy of spontaneous canine malignant melanoma. J Immunother.2013;36(6):350-358.
13.
DankGRassnickKMSokolovskyY, et al. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision. Vet Comp Oncol.2014;12(1):78-84.
14.
CanceddaSRohrer BleyCAresuL, et al. Efficacy and side effects of radiation therapy in comparison with radiation therapy and temozolomide in the treatment of measurable canine malignant melanoma. Vet Comp Oncol.2014; [Epub ahead of print]. doi: 10.1111/vco.12122.
15.
BoriaPAMurryDJBennettPF, et al. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs. J Am Vet Med Assoc.2004;224(3):388-394.
16.
FreemanKPHahnKAHarrisFDKingGK. Treatment of dogs with oral melanoma by hypofractionated radiation therapy and platinum-based chemotherapy (1987–1997). J Vet Intern Med.2003;17(1):96-101.
17.
BatemanKECattonPAPennockPWKruthSA. 0-7-21 Radiation therapy for the treatment of canine oral melanoma. J Vet Intern Med.1994;8(4):267-272.
18.
YoshikawaHHarmonJFCustisJTLarueSM. Repeatability of a planning target volume expansion protocol for radiation therapy of regional lymph nodes in canine and feline patients with head tumors. Vet Radiol Ultrasound.2012;53(6):667-672.
19.
SmithMM. Surgical approach for lymph node staging of oral and maxillofacial neoplasms in dogs. J Am Anim Hosp Assoc.1995;31(6):514-518.
20.
HerringESSmithMMRobertsonJL. Lymph node staging of oral and maxillofacial neoplasms in 31 dogs and cats. J Vet Dent.2002;19(3):122-126.
21.
WilliamsLEPackerRA. Association between lymph node size and metastasis in dogs with oral malignant melanoma: 100 cases (1987–2001). J Am Vet Med Assoc.2003;222(9):1234-1236.
22.
OdenwellerPHSmithMMTaneyKG(accepted for publication). Validation of regional lymph node excisional biopsy for staging oral and maxillofacial malignant neoplasms in 97 dogs and 10 cats (2006–2016).J Vet Dent. 2019;36(2):97-103.
23.
BostockDE. Prognosis after surgical excision of canine melanomas. Vet Pathol.1979;16(1):32-40.
24.
SmithSHGoldschmidtMHMcManusPM. A comparative review of melanocytic neoplasms. Vet Pathol.2002;39(6):651-678.
25.
BerginILSmedleyRCEsplinDGSpanglerWLKiupelM. Prognostic evaluation of Ki67 threshold value in canine oral melanoma. Vet Pathol.2011:48(1):41-53.
26.
MillantaFFratiniFCorazzaMCastagnaroMZappulliVPoliA. Proliferation activity in oral and cutaneous canine melanocytic tumors: correlation with histological parameters, location, and clinical behaviour. Res Vet Sci.2002;73(1):45-51.
27.
SpanglerWLKassPH. The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia. Vet Pathol.2006;43(2):136-149.
28.
SmedleyRCSpanglerWLEsplinDG,et al.Prognostic markers for canine melanocytic neoplasms: a comparative review of the literature and goals for future investigation. Vet Pathol.2011;48(1):54-72.
